The autoantibody response to Ro/ SSA in cutaneous lupus erythematosus.
BACKGROUND AND DESIGN: Seventeen patients with subacute cutaneous lupus erythematosus (SCLE) were compared with 15 patients with discoid lupus erythematosus (DLE) to evaluate the relationship of 60- and 52-kd Ro/ SSA autoantibodies to the clinical diagnosis and to evaluate assays for anti-Ro/ SSA. RESULTS: All serum samples from patients with SCLE had precipitating anti-Ro/ SSA antibodies in immunodiffusion, and all had high titer anti-60-kd Ro/ SSA in enzyme-linked immunosorbent assay. Immunoblotting was inadequately sensitive for detecting anti-60-kd Ro/ SSA. Fifteen patients with SCLE had anti-52-kd Ro/ SSA (11 high titer, four low titer). Only one of the 15 patients with DLE had precipitating, high-titer anti-Ro/ SSA. Nine other patients with DLE had low-titer anti-60-kd Ro/ SSA, and four had low-titer anti-52-kd Ro-SSA. Low-titer anti-Ro/ SSA did not confer an increased risk for photosensitivity in the DLE group. CONCLUSIONS: High-titer, precipitating antibodies to Ro/ SSA are typical of SCLE and unusual in DLE. Low-titer, nonprecipitating antibodies to Ro/ SSA are common in DLE and could be an indication of pathogenic factors shared with SCLE. However, low titers of anti-Ro/ SSA do not confer a significant risk for SCLE skin lesions. For the purpose of clinical evaluation of skin disease, immunodiffusion assays for anti-Ro/ SSA are cost-effective and informative.[1]References
- The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Lee, L.A., Roberts, C.M., Frank, M.B., McCubbin, V.R., Reichlin, M. Archives of dermatology. (1994) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
